# A Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing Spondylitis

> **NCT01709656** · NA · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 120 (actual)

## Conditions studied

- Ankylosing Spondylitis

## Interventions

- **BIOLOGICAL:** MSC
- **DRUG:** "celecoxib", "Celebrex®"

## Key facts

- **NCT ID:** NCT01709656
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2015-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01709656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01709656, "A Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing Spondylitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01709656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*